Czechia· CZ-0249791
PIQRAY
A alpelisib product containing alpelisib, registered in Czechia by Novartis Europharm Limited, Dublin. The same ATC class is registered in 12 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Alpelisib is registered in 12 of 19 countries.
Countries holding a registration under ATC L01EM03 (alpelisib), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 8 of them publish a price we can compare per daily dose
Alpelisib · ATC L01EM03
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of alpelisib costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Alpelisib · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- CH Switzerland$136.30
The record
At a glance
SÚKL (Czech Republic)- Active substance
- ALPELISIB
- Manufacturer
- Novartis Europharm Limited, Dublin
- Country
- Czechia (CZ)
- ATC code
- L01EM03
- ATC class
- Alpelisib
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
347 interactions on record for alpelisib.
Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Alpelisib · interactions on record
347 records
- 14 severe
- 329 moderate
- 4 minor
Most severe, free to view
- EdoxabanB01AF03severe
- RifampicinJ04AB02severe
- RifabutinJ04AB04severe
- RifapentineJ04AB05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Alpelisib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandPiqray 200 mg + 50 mg, FilmtablettenNovartis Pharma Schweiz AG
- NetherlandsPiqray 200 mg filmomhulde tablettenNovartis Europharm Limited
- NorwayPiqrayNovartis Europharm Limited (1)
- PolandPiqrayNovartis Europharm Limited
- IcelandPiqrayNovartis Europharm Limited*
- BelgiumPiqray 200 mgNovartis Europharm
- SwedenPiqray 200 mg Filmdragerad tablettNovartis Europharm Limited
- SpainPIQRAY 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULANovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Piqray, Vijoice
- Liechtenstein · Piqray, Vijoice
- Norway · Piqray, Vijoice
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/23456f0f-3ff0-4b9f-b701-cb66ce459f2a GET /v1/drugs/23456f0f-3ff0-4b9f-b701-cb66ce459f2a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "TBL FLM",
"source": "sukl",
"strength": "200MG",
"pack_size": "14",
"substance": "ALPELISIB",
"cz_kod_sukl": "0249791",
"product_type": "CH",
"substance_codes": "20375",
"registration_state": "R",
"registration_number": "EU/1/20/1455/007"
}See everything about alpelisib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.